S&P 및 Nasdaq 내재가치 문의하기

Kintara Therapeutics, Inc. KTRA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
37/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Kintara Therapeutics, Inc. (KTRA), 포함 39 건 매수3 건 매도. 내부자 매수 총액은 $5.62M 내부자 매도 총액은 RSU 보상.

최근 활동이 있는 주요 내부자에는 Bianco James A., Manuso James S J, Ng George K. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — KTRA

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2024-10-18 Bianco James A. Chief Executive Officer 알 수 없음 - - - -
2024-10-18 Bianco James A. Chief Executive Officer RSU 부여 71,560 $3.69 $264.06K 71,560
2024-10-18 Manuso James S J Director 알 수 없음 - - - -
2024-10-18 Manuso James S J Director RSU 부여 13,553 $4.14 $56.11K 13,553
2024-10-18 Ng George K Director 알 수 없음 - - - -
2024-10-18 Ng George K Director RSU 부여 13,553 $4.14 $56.11K 13,553
2024-10-18 List Alan Director 알 수 없음 - - - -
2024-10-18 List Alan Director RSU 부여 13,553 $4.14 $56.11K 13,553
2024-10-18 Dearborn Dan Chief Financial Officer 알 수 없음 - - - -
2024-10-18 Dearborn Dan Chief Financial Officer RSU 부여 15,744 $3.69 $58.1K 15,744
2024-10-18 Patel Vijay 10 Percent Owner 알 수 없음 1,315,441 $5.70 $7.5M -
2024-10-18 Yamashita Dennis Chief Scientific Officer 알 수 없음 - - - -
2024-10-18 Yamashita Dennis Chief Scientific Officer RSU 부여 196,790 $3.69 $726.16K 196,790
2023-08-30 Hoffman Robert E. President, CEO and Interim CFO RSU 부여 23,142 $4.66 $107.73K 23,142
2023-08-30 Favorito Tamara A Director RSU 부여 8,500 $4.66 $39.57K 8,500
2023-08-30 Brown Dennis M Chief Scientific Officer RSU 부여 10,175 $4.66 $47.36K 10,175
2023-08-30 Toth Robert Joseph Jr Director RSU 부여 8,500 $4.66 $39.57K 8,500
2023-08-30 Johnson Laura L. Director RSU 부여 8,500 $4.66 $39.57K 8,500
2023-06-01 Hoffman Robert E. President, CEO, and CFO RSU 부여 59,800 - - 68,902
2023-01-05 Brown Dennis M Chief Scientific Officer 상속 (매수) 363 - - 5,302
2022-08-01 Hoffman Robert E. President and CEO RSU 부여 1,200,634 - - 1,200,634
2022-08-01 Praill Anthony Scott Chief Financial Officer RSU 부여 240,087 - - 277,273
2022-08-01 Brown Dennis M Chief Scientific Officer RSU 부여 240,087 - - 246,905
2022-07-01 Seymour Tamara A Director RSU 부여 100,000 - - 100,000
2022-07-01 Toth Robert Joseph Jr Director RSU 부여 100,000 $0.26 $25.5K 100,000
2022-07-01 Johnson Laura L. Director RSU 부여 100,000 - - 100,000
2022-02-15 Hoffman Robert E. President and CEO 정보 매수 55,000 $0.47 $25.8K 55,000
2021-12-08 Praill Anthony Scott Chief Financial Officer 정보 매수 28,700 $0.68 $19.43K 37,186
2021-12-07 Zarrabian Saiid Head of Strategic Partnerships 정보 매수 38,109 $0.64 $24.3K 55,500
2021-12-06 Zarrabian Saiid Head of Strategic Partnerships 정보 매수 11,891 $0.59 $7.02K 17,391
2021-11-22 Johnson Laura L. Director 정보 매수 3,000 $0.74 $2.23K 3,000
2021-11-08 Hoffman Robert President and CEO RSU 부여 3,519,170 $0.96 $3.38M 3,519,170
2021-09-22 Hoffman Robert Director RSU 부여 100,000 $1.24 $124K 100,000
2021-09-22 Seymour Tamara A Director RSU 부여 35,000 $1.24 $43.4K 35,000
2021-09-22 Murphy Keith Director RSU 부여 100,000 $1.24 $124K 100,000
2021-09-22 Toth Robert Joseph Jr Director RSU 부여 100,000 $1.24 $124K 100,000
2021-09-22 Johnson Laura L. Director RSU 부여 100,000 $1.24 $124K 100,000
2021-04-29 Praill Anthony Scott Chief Financial Officer 전환 (매도) 3,750 - - -
2021-04-29 Brown Dennis M Chief Scientific Officer 전환 (매도) 3,000 - - -
2021-04-29 Toth Robert Joseph Jr Director 전환 (매도) 1,300 - - -
2021-04-29 Seymour Tamara A Director 알 수 없음 - - - -
2021-04-29 Seymour Tamara A Director RSU 부여 75,000 $1.37 $102.75K 75,000
2021-03-31 Praill Anthony Scott Chief Financial Officer 기타 (매수) 22 - - 7,540
2021-03-31 Brown Dennis M Chief Scientific Officer 기타 (매수) 17 - - 6,062
2021-03-31 Toth Robert Joseph Jr Director 기타 (매수) 8 - - 1,238
2020-12-31 Praill Anthony Scott Chief Financial Officer 기타 (매수) 22 - - 7,518
2020-12-31 Brown Dennis M Chief Scientific Officer 기타 (매수) 17 - - 6,045
2020-12-31 Toth Robert Joseph Jr Director 기타 (매수) 8 - - 1,230
2020-09-30 Praill Anthony Scott Chief Financial Officer 기타 (매수) 22 - - 7,496
2020-09-30 Brown Dennis M Chief Scientific Officer 기타 (매수) 17 - - 6,028
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기